| Year |
Citation |
Score |
| 2018 |
Christoph T, Raffa R, De Vry J, Schröder W. Synergistic interaction between the agonism of cebranopadol at nociceptin/orphanin FQ and classical opioid receptors in the rat spinal nerve ligation model. Pharmacology Research & Perspectives. 6: e00444. PMID 30519474 DOI: 10.1002/Prp2.444 |
0.405 |
|
| 2016 |
Pergolizzi JV, Raffa RB, LeQuang JA. The Centers for Disease Control and Prevention opioid guidelines: potential for unintended consequences and will they be abused? Journal of Clinical Pharmacy and Therapeutics. 41: 592-593. PMID 27576604 DOI: 10.1111/Jcpt.12444 |
0.317 |
|
| 2015 |
Nguyen V, Raffa RB, Taylor R, Pergolizzi JV. The role of abuse-deterrent formulations in countering opioid misuse and abuse. Journal of Clinical Pharmacy and Therapeutics. PMID 26595258 DOI: 10.1111/Jcpt.12337 |
0.337 |
|
| 2014 |
Tallarida CS, Egan E, Alejo GD, Raffa R, Tallarida RJ, Rawls SM. Levamisole and cocaine synergism: a prevalent adulterant enhances cocaine's action in vivo. Neuropharmacology. 79: 590-5. PMID 24440755 DOI: 10.1016/J.Neuropharm.2014.01.002 |
0.365 |
|
| 2008 |
Rawls SM, Gerber K, Ding Z, Roth C, Raffa RB. Agmatine: identification and inhibition of methamphetamine, kappa opioid, and cannabinoid withdrawal in planarians. Synapse (New York, N.Y.). 62: 927-34. PMID 18792993 DOI: 10.1002/Syn.20571 |
0.342 |
|
| 2008 |
Raffa RB, Stagliano GW, Ross G, Powell JA, Phillips AG, Ding Z, Rawls SM. The kappa-opioid receptor antagonist nor-BNI inhibits cocaine and amphetamine, but not cannabinoid (WIN 52212-2), abstinence-induced withdrawal in planarians: an instance of 'pharmacologic congruence'. Brain Research. 1193: 51-6. PMID 18178175 DOI: 10.1016/J.Brainres.2007.12.001 |
0.779 |
|
| 2007 |
Raffa RB, Cavallo F, Capasso A. Flumazenil-sensitive dose-related physical dependence in planarians produced by two benzodiazepine and one non-benzodiazepine benzodiazepine-receptor agonists. European Journal of Pharmacology. 564: 88-93. PMID 17368613 DOI: 10.1016/j.ejphar.2007.02.006 |
0.312 |
|
| 2007 |
Raffa RB, Stagliano GW, Tallarida RJ. Nonlinear isobologram and superadditive withdrawal from cocaine: cannabinoid combinations in planarians. European Journal of Pharmacology. 556: 89-90. PMID 17141755 DOI: 10.1016/J.Ejphar.2006.10.051 |
0.77 |
|
| 2006 |
Raffa RB, Stagliano GW, Tallarida RJ. Subadditive withdrawal from cocaine/kappa-opioid agonist combinations in Planaria. Brain Research. 1114: 31-5. PMID 16914122 DOI: 10.1016/J.Brainres.2006.07.037 |
0.784 |
|
| 2006 |
Rawls SM, Gomez T, Stagliano GW, Raffa RB. Measurement of glutamate and aspartate in Planaria. Journal of Pharmacological and Toxicological Methods. 53: 291-5. PMID 16332445 DOI: 10.1016/J.Vascn.2005.10.004 |
0.729 |
|
| 2005 |
Schulingkamp RJ, Aloyo V, Tallarida RJ, Raffa RB. Changes in aorta alpha1-adrenoceptor number and affinity during one year of streptozotocin-induced diabetes in rats. Pharmacology. 74: 23-30. PMID 15640611 DOI: 10.1159/000083211 |
0.737 |
|
| 2005 |
Umeda S, Stagliano GW, Borenstein MR, Raffa RB. A reverse-phase HPLC and fluorescence detection method for measurement of 5-hydroxytryptamine (serotonin) in Planaria. Journal of Pharmacological and Toxicological Methods. 51: 73-6. PMID 15596117 DOI: 10.1016/J.Vascn.2004.07.002 |
0.762 |
|
| 2004 |
Spencer SD, Raffa RB. Isothermal titration calorimetric study of RNase-A kinetics (cCMP --> 3'-CMP) involving end-product inhibition. Pharmaceutical Research. 21: 1642-7. PMID 15497691 DOI: 10.1023/B:Pham.0000041460.78128.0F |
0.623 |
|
| 2004 |
Umeda S, Stagliano GW, Raffa RB. Cocaine and kappa-opioid withdrawal in Planaria blocked by D-, but not L-, glucose. Brain Research. 1018: 181-5. PMID 15276876 DOI: 10.1016/J.Brainres.2004.05.057 |
0.771 |
|
| 2004 |
Raffa RB, Stagliano GW, Spencer SD. Protonation effect on drug affinity. European Journal of Pharmacology. 483: 323-4. PMID 14729124 DOI: 10.1016/J.Ejphar.2003.10.019 |
0.736 |
|
| 2003 |
Raffa RB, Stagliano GW, Umeda S. kappa-Opioid withdrawal in Planaria. Neuroscience Letters. 349: 139-42. PMID 12951188 DOI: 10.1016/S0304-3940(03)00814-0 |
0.782 |
|
| 2002 |
Raffa RB, Spencer SD, Schulingkamp RJ. Toward RNase inhibitors: thermodynamics of 2'-CMP/RNase-A binding in multi-ion buffer. Biochemical Pharmacology. 63: 1937-9. PMID 12093469 DOI: 10.1016/S0006-2952(02)00977-2 |
0.731 |
|
| 2002 |
Citver AS, Shields AM, Ciaccia LM, Schulingkamp RJ, Raffa RB. Indirect modulation of dopamine D2 receptors as potential pharmacotherapy for schizophrenia: III. Retinoids. Journal of Clinical Pharmacy and Therapeutics. 27: 161-8. PMID 12081629 DOI: 10.1046/J.1365-2710.2002.00410.X |
0.759 |
|
| 2002 |
Spencer SD, Abdul O, Schulingkamp RJ, Raffa RB. Toward the design of ribonuclease (RNase) inhibitors: ion effects on the thermodynamics of binding of 2'-CMP to RNase A. The Journal of Pharmacology and Experimental Therapeutics. 301: 925-9. PMID 12023520 DOI: 10.1124/Jpet.301.3.925 |
0.73 |
|
| 2001 |
Raffa RB, Holland LJ, Schulingkamp RJ. Quantitative assessment of dopamine D2 antagonist activity using invertebrate (Planaria) locomotion as a functional endpoint. Journal of Pharmacological and Toxicological Methods. 45: 223-6. PMID 11755386 DOI: 10.1016/S1056-8719(01)00152-6 |
0.777 |
|
| 2000 |
Schulingkamp RJ, Pagano TC, Hung D, Raffa RB. Insulin receptors and insulin action in the brain: review and clinical implications. Neuroscience and Biobehavioral Reviews. 24: 855-72. PMID 11118610 DOI: 10.1016/S0149-7634(00)00040-3 |
0.729 |
|
| 2000 |
Raffa RB, Valdez JM, Holland LJ, Schulingkamp RJ. Energy-dependent UV light-induced disruption of (-)sulpiride antagonism of dopamine. European Journal of Pharmacology. 406: R11-2. PMID 11040357 DOI: 10.1016/S0014-2999(00)00730-5 |
0.76 |
|
| 1994 |
Raffa RB, Codd EE. Lack of glibenclamide or TEA affinity for opioid receptors: further evidence for in vivo modulation of antinociception at K+ channels. Brain Research. 650: 146-8. PMID 7953665 DOI: 10.1016/0006-8993(94)90217-8 |
0.304 |
|
| Show low-probability matches. |